Sei Investments Co. Acquires 349,861 Shares of Oscar Health, Inc. $OSCR

Sei Investments Co. grew its holdings in Oscar Health, Inc. (NYSE:OSCR) by 695.7% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 400,149 shares of the company’s stock after acquiring an additional 349,861 shares during the period. Sei Investments Co.’s holdings in Oscar Health were worth $4,590,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in OSCR. First Trust Advisors LP raised its position in shares of Oscar Health by 13.7% during the 1st quarter. First Trust Advisors LP now owns 346,214 shares of the company’s stock valued at $3,971,000 after buying an additional 41,714 shares in the last quarter. IVY Lane Capital Management LLC purchased a new position in Oscar Health in the first quarter worth about $574,000. Convergence Investment Partners LLC purchased a new position in Oscar Health in the first quarter worth about $1,208,000. Dimensional Fund Advisors LP increased its stake in Oscar Health by 22.1% during the first quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company’s stock worth $48,078,000 after acquiring an additional 759,837 shares during the last quarter. Finally, SEB Asset Management AB purchased a new stake in Oscar Health during the first quarter valued at approximately $5,776,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Mario Schlosser sold 147,500 shares of the firm’s stock in a transaction that occurred on Tuesday, June 23rd. The shares were sold at an average price of $29.38, for a total transaction of $4,333,550.00. Following the transaction, the director directly owned 1,360,866 shares of the company’s stock, valued at approximately $39,982,243.08. This trade represents a 9.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Janet Liang sold 12,475 shares of Oscar Health stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $273,701.50. Following the sale, the insider directly owned 259,057 shares of the company’s stock, valued at $5,683,710.58. This represents a 4.59% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 3,662,466 shares of company stock worth $105,145,815 over the last 90 days. Corporate insiders own 22.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a report on Monday, July 6th. Wells Fargo & Company set a $20.00 price objective on shares of Oscar Health and gave the stock an “equal weight” rating in a research note on Thursday, June 4th. Jefferies Financial Group raised shares of Oscar Health from an “underperform” rating to a “hold” rating and increased their target price for the company from $10.00 to $16.00 in a research note on Monday, April 20th. Barclays raised shares of Oscar Health from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $30.00 to $35.00 in a research note on Wednesday, June 10th. Finally, Weiss Ratings raised shares of Oscar Health from a “sell (d)” rating to a “sell (d+)” rating in a research report on Friday, July 10th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $22.00.

Oscar Health Stock Down 0.7%

Shares of OSCR opened at $30.17 on Thursday. The firm has a market capitalization of $9.10 billion, a P/E ratio of -51.14, a P/E/G ratio of 0.89 and a beta of 2.36. Oscar Health, Inc. has a 12-month low of $10.69 and a 12-month high of $33.10. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. The firm has a fifty day moving average price of $28.74 and a 200-day moving average price of $20.25.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping the consensus estimate of $1.11 by $0.96. The company had revenue of $4.65 billion for the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The firm’s revenue was up 52.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.92 EPS. Equities research analysts expect that Oscar Health, Inc. will post 1.12 earnings per share for the current year.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.